Aarti Drugs Limited
NSE: AARTIDRUGS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Prakash Moreshwar Patil
- Employees
- 1,064
- Headquarters
- Mumbai, India
- IPO year
- 2003
- Market cap
- ₹35.4B
- Website
- https://www.aartidrugs.co.in
Loading AARTIDRUGS…
Loading profile data…Frequently asked questions about AARTIDRUGS
What does Aarti Drugs Limited (AARTIDRUGS.NS) do?
Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheime...
Where does AARTIDRUGS.NS trade?
Aarti Drugs Limited (AARTIDRUGS.NS) trades on the National Stock Exchange of India.
What sector is AARTIDRUGS.NS in?
Aarti Drugs Limited (AARTIDRUGS.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aarti Drugs Limited?
Prakash Moreshwar Patil is the chief executive officer of Aarti Drugs Limited (AARTIDRUGS.NS).
Where is Aarti Drugs Limited headquartered?
Aarti Drugs Limited is headquartered in India.
Does AARTIDRUGS.NS pay a dividend?
Yes — Aarti Drugs Limited (AARTIDRUGS.NS) paid a trailing twelve-month dividend of INR 2.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did AARTIDRUGS.NS go public?
Aarti Drugs Limited (AARTIDRUGS.NS) completed its initial public offering in 2003.